Purine biosynthesis enzyme (multiple family members)

These are a family of enzymes responsible for the synthesis of purine nucleotides (adenine, guanine) required for DNA and RNA production, as well as numerous cellular signaling and energy transfer reactions. The enzymes can be grouped by their function in the metabolic network: de novo purine biosynthesis (steps converting PRPP into IMP then to AMP or GMP), salvage pathways (recycling free bases), and breakdown pathways (catabolizing to uric acid). In humans, the enzymes frequently assemble into multi-protein complexes (purinosomes) under high metabolic demand. Aberrant activity or expression is implicated in cancer proliferation, metabolic, immunological, and neurological diseases, making them important therapeutic targets. However, the entry "DNA/RNA and purine biosynthesis enzymes" is a non-specific label and should be subdivided into specific named enzymes for precision.

Other names

De novo purine biosynthesis enzymesnucleotide synthesis enzymespurinosome (for complex)individual names for each enzyme (e.g., hypoxanthine-guanine phosphoribosyltransferase (HGPRT), amidophosphoribosyltransferase (PPAT), phosphoribosylglycinamide formyltransferase (GART), etc.)

Competitive inhibition of enzyme active site (purine analogs); Inhibition of substrate binding or cofactor function; Disruption of enzyme complex assembly (purinosome disruptors); Feedback inhibition via pathway end-products (e.g., AMP, GMP inhibit PPAT)